Back to search
FDAFDA · Food and drugs·Recall number D-0608-2026

Focalin XR (dexmethylphenidate HCl) 5 mg, 30 extended-release capsules per bottle, Rx only, Manufactured by Societal CDMO Gainesville, LLC, Gainesville, GA 30504. NDC: 66758-235-31

Published June 24, 2026 · Recall initiated: June 1, 2026

Summary

FDA records drug Class III recall D-0608-2026, published June 24, 2026 and initiated June 1, 2026. Recalling firm: Sandoz Inc; Status: Ongoing; Reported quantity: 7,803 bottles; Lot: Lot VA0099422; Exp. Date June 30, 2028. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Exp Date

What to do

Voluntary: Firm initiated · Letter

Get an email if FOCALIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FOCALIN
Manufacturer
Sandoz Inc
Distributor
U.S. Nationwide
Lot
Lot VA0099422; Exp. Date June 30, 2028
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Focalin XR (dexmethylphenidate HCl) 5 mg, 30 extended-release capsules per bottle, Rx only, Manufactured by Societal CDMO Gainesville, LLC, Gainesville, GA 30504. NDC: 66758-235-31 recalled?

Yes. FDA published recall D-0608-2026 on June 24, 2026. Reported hazard: Labeling: Incorrect or Missing Lot and/or Exp Date

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FOCALIN.